A new standard of care for treatment of ovarian cancer.
Piccart
M J
MJ
Institut Jules Bordet, Unite de Cancerologie Mammaire et Gynecologie, Brussels, Belgium. mpiccart@ulb.ac.be
Du Bois
A
A
Gore
M E
ME
Neijt
J P
JP
Pecorelli
S
S
Pujade-Lauraine
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage; D011787:Quality of Health Care; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis
D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin